Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery
Explore this paper's citation graph
Summary
Among patients with multivessel disease and severe left ventricular systolic dysfunction, PCI with everolimus-eluting stent had comparable long-term survival in comparison with CABG.
- Type
- article
- Published
- 2016-05-31
- Cited by
- 131
- References
- 31
- OpenAlex
- https://openalex.org/W27151532
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27386050
Keywords
Computer science
References
- ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization
- Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease
- Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features
- Results of coronary artery surgery in patients with poor left ventricular function (CASS).
- Revascularization in severe left ventricular dysfunction: Outcome comparison of drug‐eluting stent implantation versus coronary artery by‐pass grafting
- Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.
- Revascularization in patients with heart failure
- Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
- ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
- Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).
- Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%.
- Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.
- Trial of everolimus-eluting stents or bypass surgery for coronary disease.
- 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.
- Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
- The central role of the propensity score in observational studies for causal effects
- Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
- Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
Cited by
- Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction: Do We Have the Evidence?
- Interventional therapies in ischemic ventricular dysfunction: facts and versions!
- Challenges with Evidence-Based Management of Stable Ischemic Heart Disease
- Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
- Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
- Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
- Interventional Therapies for Heart Failure in Older Adults.
- Left main or multivessel coronary revascularization: applying both anatomy and physiology to individualize care.
- Stable coronary artery disease and left ventricular dysfunction: The role of revascularization
- Coronary artery bypass graft: Is it still an elixir of life?
- Atherosclerotic Cardiovascular Disease in Older Adults
- Systemic metabolism and energy consumption after microsurgical clipping and endovascular coiling for aneurysmal subarachnoid hemorrhage
- Pathology of stent implantation in internal mammary artery
- Ischemic left ventricle systolic dysfunction: An evidence-based approach in diagnostic tools and therapeutics.
- Stents liberadores de medicamentos en enfermedad coronaria multivaso (dos y tres vasos)
- Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies: A Prospective Cohort Study
- The Potential Effects of New Stent Platforms for Coronary Revascularization in Patients With Diabetes.
- Viability testing to guide myocardial revascularisation in patients with heart failure
- Comparison of three treatment strategies for patients with triple‐vessel coronary disease and left ventricular dysfunction
- Revascularization in stable coronary disease: evidence and uncertainties
Related papers
No related papers recorded.